Improving Organ Donation and Transplantation in the European Union: Assessing the Impacts of European Action

Jan Tiessen ; Annalijn Conklin ; Barbara Janta ; Lila Rabinovich ; Han de Vries ; Evi Hatziandreu ; Bhanu Patruni ; Tom Ling

RAND Corporation

RAND Corporation

关键词: European Union;    Health and Health Care;    Public Sector Governance;   

RP-ID  :  TR-602-EC

学科分类：自然科学（综合）

美国|英语

来源: RAND Corporation Published Research

【 摘 要 】

Due to rapid advances in transplantation medicine, the use of human organs for transplantation has steadily increased during the past decades. Organ transplantation is now the most cost-effective treatment for end-stage renal failure and the only available, life-saving treatment for end-stage failure of organs such as liver, lung and heart. The advancement of transplantation medicine has led, however, to a shortage in available organs and poses new quality and safety challenges. Against this background the European Commission aims to improve the availability of organs, ensure their quality and safety, and make transplantation systems more efficient and accessible through European action. In this context the European Commission commissioned RAND Europe to provide support for assessing the impacts of four policy options to improve organ donation and transplantation in the European Union. By taking into account the evidence on possible health, economic and social impacts, this report thus weighs the costs and benefits of the proposed policy options and supports the identification of a preferred policy option to meet DG SANCO's objectives. The qualitative analysis in this report is supplemented by a scenario modelling and benchmarking exercise to address some of the inherent uncertainties related to an impact assessment of relatively broad policy options.